The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Differential membrane binding of the human immunodeficiency virus type 1 matrix protein
Open accessAbstract
The human immunodeficiency virus type 1 matrix protein (p17MA) plays a central role at both the early and late stages of the virus life cycle. During viral assembly, the p17MA domain of Pr55gag promotes membrane association, which is essential for the formation of viral particles. When viral infection occurs, the mature p17MA dissociates from the plasma membrane and participates in the nuclear targeting process. Thus, p17MA contains a reversible membrane binding signal to govern its differential subcellular localization and biological functions. We previously identified a membrane binding signal within the amino-terminal 31 amino acids of the matrix domain of human immunodeficiency virus type 1 Gag, consisting of myristate and a highly basic region (W. Zhou, L. J. Parent, J. W. Wills, and M. D. Resh, J. Virol. 68:2556-2569, 1994). Here we show that exposure of this membrane binding signal is regulated in different Gag protein contexts. Within full-length Pr55gag, the membrane targeting signal is exposed and can direct Pr55gag as well as heterologous proteins to the plasma membrane. However, in the context of p17MA alone, this signal is hidden and unable to confer plasma membrane binding. To investigate the molecular mechanism for regulation of membrane binding, a series of deletions within p17MA was generated by sequentially removing alpha-helical regions defined by the nuclear magnetic resonance structure. Removal of the last alpha helix (amino acids 97 to 109) of p17MA was associated with enhancement of binding to biological membranes in vitro and in vivo. Liposome binding experiments indicated that the C-terminal region of p17MA exerts a negative effect on the N-terminal MA membrane targeting domain by sequestering the myristate signal. We propose that mature p17MA adopts a conformation different from that of the p17MA domain within Pr55gag and present evidence to support this hypothesis. It is likely that such a conformational change results in an N-terminal myristyl switch which governs differential membrane binding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,511
Heim, R., Cubitt, A. B., & Tsien, R. Y. (1995) · Nature · doi:10.1038/373663b0 · Cited by 1,821
A simple method for the preparation of homogeneous phospholipid vesicles
Barenholz, Y., Gibbes, D. C., Litman, B. J., Goll, J., Thompson, T. E., & Carlson, F. D. (1977) · Biochemistry · doi:10.1021/bi00631a035 · Cited by 864
Heinzinger, N. K., Bukinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V, Lee, M. A., Gendelman, H. E., Ratner, L., Stevenson, M., & Emerman, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7311 · Cited by 854
Göttlinger, H. G., Sodroski, J. G., & Haseltine, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5781 · Cited by 841
Bukrinsky, M., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubei, A. A., Spitz, L., Lewis, P. F., Goldfarb, D. S., Emerman, M., & Stevenson, M. (1993) · Nature · doi:10.1038/365666a0 · Cited by 801
Lewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797
THE BIOLOGY AND ENZYMOLOGY OF EUKARYOTIC PROTEIN ACYLATION
Towler, D. A., Gordon, J. I., Adams, S. P., & Glaser, L. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.000441 · Cited by 793
Gheysen, D., Jacobs, E. J., de Foresta, F., Thiriart, C., Francotte, M., Thines, D., & Wilde, M. D. (1989) · Cell · doi:10.1016/0092-8674(89)90873-8 · Cited by 743
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release
Göttlinger, H. G., Dorfman, T., Sodroski, J. G., & Haseltine, W. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3195 · Cited by 647
Cited by
Sorted by citations
Resh, M. D. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00075-0 · Cited by 1,247
Self-citationHIV-1 Gag proteins: diverse functions in the virus life cycle
Freed, E. O. (1998) · Virology · doi:10.1006/viro.1998.9398 · Cited by 717
“, 1997), together with the finding that deletions in the C terminus of MA (Zhou and Resh, 1996) or throughout the protein (Spearman et al.”
BackgroundInfluentialPlasma membrane rafts play a critical role in HIV-1 assembly and release
Ono, A., & Freed, E. O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241320298 · Cited by 700
Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly
Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H., & Summers, M. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602818103 · Cited by 545
The structural biology of HIV assembly
Ganser‐Pornillos, B. K., Yeager, M. J., & Sundquist, W. I. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.02.001 · Cited by 500
The structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 499
“The differential exposure of the myristic acid, through a process known as the myristyl switc”
BackgroundFunctional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein
von Schwedler, U. K., Stray, K. M., Garrus, J. E., & Sundquist, W. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5439-5450.2003 · Cited by 421
Garoff, H., Hewson, R., & Opstelten, D.-J. E. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1171-1190.1998 · Cited by 359
“These include (i) the expression of Gag precursors and precursor variants in cells and the analyses of their membranebinding and particle-forming capabilities (90, 118, 215, 271, 310), (ii) in vitro synthesis of Gag related peptides and analysis of their interaction with liposomes (309), and (iii) purification of Gag…”
BackgroundEntropic switch regulates myristate exposure in the HIV-1 matrix protein
Tang, C., Loeliger, E., Luncsford, P. J., Kinde, I., Beckett, D., & Summers, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305665101 · Cited by 320
Freed, E. O. (2001) · Somatic Cell and Molecular Genetics · doi:10.1023/a:1021070512287 · Cited by 307
Ono, A., & Freed, E. O. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1552-1563.2004 · Cited by 275
“In the case of human immunodeficiency virus type 1 (HIV-1), the Gag precursor, Pr55Gag, is cleaved by PR into four mature Gag proteins, i.e., p17 matrix (MA), p24 capsid (CA), p7 nucleocapsid (NC), and p6, and two spacer peptides, i.e., p2 and p1 (11, 55).”
BackgroundInfluentialChukkapalli, V., Hogue, I. B., Boyko, V., Hu, W.-S., & Ono, A. (2008) · Journal of Virology · doi:10.1128/jvi.01614-07 · Cited by 268
“The myristate moiety is considered to be regulated by a mechanism termed a myristoyl switch (30, 57, 65, 72, 74, 75, 80, 84, 94).”
BackgroundMethodInfluentialCryo-electron microscopy reveals ordered domains in the immature HIV-1 particle
Fuller, S. D., Wilk, T., Gowen, B. E., Kräusslich, H., & Vogt, V. M. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00331-9 · Cited by 246
“The MA sequences include a carboxy-terminal α helix in the crystal structure [42,43], which juts away from the putative membrane-binding portion and has been shown to affect the conformation of the amino-terminal portion of MA by in vitro membrane binding [52].”
BackgroundLindwasser, O. W., & Resh, M. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7913-7924.2001 · Cited by 244
“viously (69) with the exception that the enhanced GFP (eGFP) coding sequence”
BackgroundSelf-citationRole of the Gag Matrix Domain in Targeting Human Immunodeficiency Virus Type 1 Assembly
Ono, A., Orenstein, J. M., & Freed, E. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2855-2866.2000 · Cited by 239
“This mutation abolishes Pr55 myristylation and severely impairs Gag membrane binding (4, 45, 61, 71).”
BackgroundEfficient HIV‐1 replication can occur in the absence of the viral matrix protein
Reil, H., Bukovsky, A. A., Gelderblom, H. R., & Göttlinger, H. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2699 · Cited by 241
“Our finding that large deletions in MA increased particle yields may be explained by a recently proposed myristyl switch model of Gag membrane binding (Zhou and Resh, 1996).”
BackgroundBinding of Human Immunodeficiency Virus Type 1 Gag to Membrane: Role of the Matrix Amino Terminus
Ono, A., & Freed, E. O. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4136-4144.1999 · Cited by 238
“p17 (MA) thus displays a significantly reduced affinity for membrane compared with Pr55 (42, 55).”
BackgroundInfluentialChukkapalli, V., Oh, S. J., & Ono, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908661107 · Cited by 229
“This mechanism is known as the myristoyl switch (8, 9).”
BackgroundSpearman, P. W., Horton, R., Ratner, L., & Kuli-zade, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6582-6592.1997 · Cited by 204
“One explanation for the discrepant findings is that the addition of dihydrofolate reductase, green fluorescent protein, or bgalactosidase to the C terminus of MA in the studies of Zhou and Resh may have altered the structure of the globular head of MA.”
BackgroundInfluentialMaurer‐Stroh, S., Eisenhaber, B., & Eisenhaber, F. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2002.5425 · Cited by 203
More than one door – Budding of enveloped viruses through cellular membranes
Welsch, S., Müller, B., & Kräusslich, H. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.060 · Cited by 197
“Several retroviral Gag polyproteins have been proposed or shown to contain a cluster of basic amino acids in addition to N-terminal acylation [36,38].”
Human immunodeficiency virus type 1 assembly, release, and maturation
Adamson, C. S., & Freed, E. O. (2007) · Advances in Pharmacology · doi:10.1016/s1054-3589(07)55010-6 · Cited by 179
Murakami, T., Ablan, S. D., Freed, E. O., & Tanaka, Y. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.1026-1031.2004 · Cited by 172
“It has been postulated that Gag processing induces conformational changes in the matrix (MA) domain of Gag (25, 44, 59).”
BackgroundLipids and membrane microdomains in HIV-1 replication
Waheed, A. A., & Freed, E. O. (2009) · Virus Research · doi:10.1016/j.virusres.2009.04.007 · Cited by 173
“…membrane targeting of HIV-1 Gag is regulated by a highly basic cluster of amino acids located between MA residues 17 and 31 (Freed et al., 1994; Hermida-Matsumoto and Resh, 2000; Ono et al., 2000a; Ono and Freed, 1999; Ono and Freed, 2004; Ono et al., 1997; Yuan et al., 1993; Zhou and Resh, 1996).”
BackgroundRuigrok, R. W. H., Schoehn, G., Dessen, A., Forest, É., Volchkov, V. E., Dolnik, O., Klenk, H., & Weissenhorn, W. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3822 · Cited by 151
Paillart, J., & Göttlinger, H. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2604-2612.1999 · Cited by 151
“Such a model was originally proposed by Zhou and Resh to explain the relatively low affinity of mature MA for membranes, which may allow it to dissociate from the plasma membrane to participate in the nuclear import of the viral genome (53).”
BackgroundMethodResultInfluentialAnalysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids
Alfadhli, A., Still, A., & Barklis, E. (2009) · Journal of Virology · doi:10.1128/jvi.01197-09 · Cited by 145
Sandefur, S., Varthakavi, V., & Spearman, P. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2723-2732.1998 · Cited by 152
“Previous work has demonstrated that HIV-1 Pr55 binds more efficiently to cellular or phospholipid vesicle membranes than MA (39, 40, 48).”
BackgroundDale, B. M., McNerney, G. P., Thompson, D. L., Hubner, W., de los Reyes, K., Chuang, F. Y. S., Huser, T., & Chen, B. K. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.015 · Cited by 133
“05% saponin, and stained with a monoclonal antibody that recognizes p17 only in the context of mature virus (Ono et al., 2000; Zhou and Resh, 1996).”
InfluentialRole of Matrix in an Early Postentry Step in the Human Immunodeficiency Virus Type 1 Life Cycle
Kiernan, R. E., Ono, A., Englund, G., & Freed, E. O. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4116-4126.1998 · Cited by 132
“It has been observed that Pr55 binds membrane more tightly than MA itself (55, 64, 79), suggesting that cleavage of Pr55 may trigger conformational changes in MA which reduce its affinity for membrane.”
BackgroundMolecular determinants that regulate plasma membrane association of HIV-1 Gag
Chukkapalli, V., & Ono, A. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.015 · Cited by 129
Hogue, I. B., Grover, J. R., Soheilian, F., Nagashima, K., & Ono, A. (2011) · Journal of Virology · doi:10.1128/jvi.00743-11 · Cited by 129
“Prior to membrane binding, the myristoyl moiety is sequestered in a hydrophobic patch on the MA domain (129), and its exposure may be regulated by PI(4,5)P2 binding (118) and multimerization of Gag molecules (129, 146).”
BackgroundAlfadhli, A., Barklis, R. L., & Barklis, E. (2009) · Virology · doi:10.1016/j.virol.2009.02.048 · Cited by 125
“Molecular biology experiments have demonstrated that MA plays essential roles in targeting PrGag proteins to membranes for assembly, and in incorporation of HIV SU/TM (gp120/gp41) envelope (Env) protein trimers into virus particles (Yu et al., 1992; Wang and Barklis, 1993; Wang et al., 1993; Facke et al., 1993; Dorfma…”
InfluentialAssociation of Nef with the Human Immunodeficiency Virus Type 1 Core
Kotov, A., Zhou, J., Flicker, P. F., & Aiken, C. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8824-8830.1999 · Cited by 123
“In this manner, Nef may be removed from the viral membrane by a process analogous to the myristoyl switch mechanism proposed for regulating the association between the HIV-1 MA protein and the plasma membrane of the cell (41).”
BackgroundBorsetti, A., Öhagen, Å., & Göttlinger, H. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9313-9317.1998 · Cited by 126
“A possible explanation for the increased particle yields relative to those of the wild type is offered by the recently proposed myristyl switch model of Gag membrane targeting (35).”
BackgroundMyristoylation as a target for inhibiting HIV assembly: Unsaturated fatty acids block viral budding
Lindwasser, O. W., & Resh, M. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212409999 · Cited by 114
Self-citationDalton, A. K., Ako-Adjei, D., Murray, P. S., Murray, D., & Vogt, V. M. (2007) · Journal of Virology · doi:10.1128/jvi.02757-06 · Cited by 118
“Other in vitro studies of the binding of myristoylated HIV-1 proteins to membranes used proteins derived from a rabbit reticulocyte in vitro transcription and translation system (15, 21, 50, 71, 72), which yields a radiochemically pure protein that is easily monitored.”
InfluentialRole of HIV-1 Gag domains in viral assembly
Scarlata, S., & Carter, C. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00163-9 · Cited by 111
Nuclear Import of Human Immunodeficiency Virus Type-1 Preintegration Complexes
Fouchier, R. A. M., & Malim, M. H. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60302-4 · Cited by 115
Relationship between Human Immunodeficiency Virus Type 1 Gag Multimerization and Membrane Binding
Ono, A., Demirov, D. G., & Freed, E. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5142-5150.2000 · Cited by 113
“According to this model, the myristate moiety is highly exposed in the context of Pr55 but is sequestered within p17(MA) following proteolytic cleavage of the precursor by PR (21, 48, 63).”
BackgroundTritel, M., & Resh, M. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.5845-5855.2000 · Cited by 113
“p65-Gag-green fluorescent protein (GFP) chimeras have been previously described (36).”
BackgroundSelf-citationSandefur, S. L., Smith, R. M., Varthakavi, V., & Spearman, P. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7238-7249.2000 · Cited by 113
“Several groups have now provided supporting data for the presence of the myristyl switch within MA (25, 26, 30, 43).”
BackgroundMembrane association induces a conformational change in the Ebola virus matrix protein
Scianimanico, S., Schoehn, G., Timmins, J., Ruigrok, R. W. H., Klenk, H., & Weissenhorn, W. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6732 · Cited by 110
The Role of Lipids in Retrovirus Replication
Waheed, A. A., & Freed, E. O. (2010) · Viruses · doi:10.3390/v2051146 · Cited by 121
“Mutating basic residues in the MA domain mistargets Gag, such that it associates with internal compartments rather than the plasma membrane [122,163–169].”
Point Mutations in the HIV-1 Matrix Protein Turn Off the Myristyl Switch
Saad, J. S., Loeliger, E., Luncsford, P. J., Liriano, M., Tai, J., Kim, A., Miller, J. L., Joshi, A., Freed, E. O., & Summers, M. F. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.068 · Cited by 119
Larson, D. R., Ma, Y. M., Vogt, V. M., & Webb, W. W. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303200 · Cited by 109
“Second, HIV-1 MA is reported to bind to membranes in vitro less efficiently than full-length Gag, suggesting a cooperative role for Gag multimerization in this process (Zhou and Resh, 1996; Sandefur et al., 1998).”
BackgroundOno, A., Waheed, A. A., & Freed, E. O. (2006) · Virology · doi:10.1016/j.virol.2006.10.011 · Cited by 106
“In the WT context, Gag multimerization likely promotes the exposure of the myristate moiety (Hermida-Matsumoto and Resh, 1999;Perez-Caballero et al., 2004;Sandefur et al., 2000;Sandefur et al., 1998;Spearman et al., 1997;Tang et al., 2004;Zhou and Resh, 1996).”
BackgroundA myristoyl switch regulates membrane binding of HIV-1 Gag
Resh, M. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308043101 · Cited by 103
Self-citationSaad, J. S., Ablan, S. D., Ghanam, R. H., Kim, A., Andrews, K., Nagashima, K., Soheilian, F., Freed, E. O., & Summers, M. F. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.027 · Cited by 95
Murray, P. S., Li, Z., Wang, J., Tang, C. L., Honig, B. H., & Murray, D. (2005) · Structure · doi:10.1016/j.str.2005.07.010 · Cited by 98
“Hence, the membrane binding free energies for both monomeric HIV-1 Gag and EIAV Gag are weak (w−5 kcal/mol) but sufficient to direct a significant amount of protein to the plasma membrane surface, which is preferentially enriched in acidic phospholipids with respect to other intracellular membranes (Pomorski et al., 2…”
BackgroundInfluentialInteractions Between Virus Proteins and Host Cell Membranes During the Viral Life Cycle
Villanueva, R. A., Rouillé, Y., & Dubuisson, J. (2005) · International review of cytology · doi:10.1016/s0074-7696(05)45006-8 · Cited by 94
Maurer‐Stroh, S., Gouda, M., Novatchkova, M., Schleiffer, A., Schneider, G., Sirota, F. L., Wildpaner, M., Hayashi, N., & Eisenhaber, F. (2004) · Genome biology · doi:10.1186/gb-2004-5-3-r21 · Cited by 95
“Complex conformational switches can trigger changes in accessibility of the lipid moiety [10-13].”
BackgroundHermida-Matsumoto, L., & Resh, M. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1902-1908.1999 · Cited by 95
“This steady-state distribution of p17MA was similar to that found for p17MA expressed exogenously in vitro and in vivo (30, 39).”
BackgroundMethodResultInfluentialSelf-citationThe Role of Ubiquitin in Retroviral Egress
Martin‐Serrano, J. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00609.x · Cited by 92
Derdowski, A., Ding, L.-M., & Spearman, P. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1230-1242.2004 · Cited by 110
“The M domain is essential for mediating interactions of the Gag polyprotein with the inner leaflet of the plasma membrane, where both myristic acid and electrostatic interactions between basic residues within the N-terminal end of MA and negatively charged membrane phospholipids play a role (14, 46).”
BackgroundHow HIV-1 Gag assembles in cells: Putting together pieces of the puzzle
Lingappa, J. R., Reed, J. C., Tanaka, M., Chutiraka, K., & Robinson, B. A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.001 · Cited by 91
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Paillart and Gottlinger, 1999; Perez-Caballero et al., 2004; Saad et al., 2007; Spearman et al., 1997; Tang et al., 2004; Zhou and Resh, 1996), discussed further in Section 3.2.”
BackgroundInfluentialOno, A., Waheed, A. A., Joshi, A., & Freed, E. O. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14131-14140.2005 · Cited by 91
“, MA-CA) have suggested that Gag multimerization can enhance both membrane binding and DRM association (51, 74, 75, 78, 100).”
BackgroundOno, A., Huang, M. ‐., & Freed, E. O. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4409-4418.1997 · Cited by 91
“It is possible that the structures of p17 (MA) and the MA domain of Pr55 are not equivalent; the observation that an anti-MA monoclonal antibody reacts with p17 (MA) but not with Pr55 (25, 39) suggests that this is the case.”
BackgroundMurray, D., Arbuzova, A., Honig, B. H., & McLaughlint, S. (2002) · Current topics in membranes · doi:10.1016/s1063-5823(02)52012-3 · Cited by 89
“…of the BIV-l matrix domain is regulated by proteolysis: In the context of a newly formed virion, the Gag polyprotein is cleaved by the viral protease, exposing an as-yet-unknown "signal" on the matrix domain that sequesters the myristate chain (Spearman et at., 1997; Zhou and Resh, 1996).”
BackgroundLi, H., Dou, J., Ding, L., & Spearman, P. W. (2007) · Journal of Virology · doi:10.1128/jvi.01280-07 · Cited by 89
“The interaction of the N terminus of Gag with membranes is facilitated by a myristoyl switch (31, 37, 45).”
BackgroundPérez-Caballero, D., Hatziioannou, T., Martin‐Serrano, J., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9560-9563.2004 · Cited by 86
“These effects confer concentration dependence on the HIV-1 Gag-membrane interaction and are consistent with the notion that multimerization triggers the “myristoyl switch” (18, 22, 25), thereby imparting a high degree of cooperativity on HIV-1 Gag trafficking to membranes.”
BackgroundHamard-Peron, E., Juillard, F., Saad, J. S., Roy, C., Roingeard, P., Summers, M. F., Darlix, J.-L., Picart, C., & Muriaux, D. (2010) · Journal of Virology · doi:10.1128/jvi.01134-09 · Cited by 92
“, a conformational change during which the N-terminal myristoylation of Gag, initially sequestered in the MA, becomes exposed and is able to interact with membrane phospholipids (25, 40, 45, 47, 48, 53, 55, 61).”
BackgroundLlewellyn, G. N., Hogue, I. B., Grover, J. R., & Ono, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001167 · Cited by 88
“When cells expressing Gag-iYFP were immunostained with an anti-p17MA antibody, which only recognizes the mature, cleaved matrix domain of Gag [100,101], the YFP signal was observed to colocalize substantially with p17MA signal at the uropod (Figure 2A and Table 3).”
BackgroundHIV Type 1 Gag as a Target for Antiviral Therapy
Waheed, A. A., & Freed, E. O. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0230 · Cited by 84
“Resh and colleagues proposed that Gag– membrane binding is regulated by a ‘‘myristyl switch’’ mechanism, whereby the myristate can shift between exposed and sequestered conformations.(39) Summers and coworkers used nuclear magnetic resonance (NMR) methods to confirm this hypothesis and to demonstrate that myristate ex…”
BackgroundHogue, I. B., Hoppe, A. D., & Ono, A. (2009) · Journal of Virology · doi:10.1128/jvi.02545-08 · Cited by 79
“74, 82), and others previously reported that mutations or truncations of NC affect membrane binding (13, 78, 89, 107).”
Vlach, J., & Saad, J. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216655110 · Cited by 77
Biomedicine and Diseases: Review¶Assembling the human immunodeficiency virus type 1
Cimarelli, A., & Darlix, J. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8495-6 · Cited by 79
Inlora, J., Chukkapalli, V., Derse, D., & Ono, A. (2011) · Journal of Virology · doi:10.1128/jvi.02383-10 · Cited by 73
Functions of the HIV-1 matrix protein p17.
Fiorentini, S., Marini, E., Caracciolo, S., & Caruso, A. (2006) · PubMed · Cited by 72
Liang, C., Hu, J., Whitney, J. B., Kleiman, L., & Wainberg, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.1772-1783.2003 · Cited by 72
“This concept agrees with the myristyl switch model in which a lesser extent of exposure of myristate acid is believed to be the reason for the weak association of MA with the plasma membrane in comparison with the results observed for Pr55 (27, 48, 55, 68).”
ResultSpecific Interaction of a Novel Foamy Virus Env Leader Protein with the N-Terminal Gag Domain
Wilk, T., Geiselhart, V., Frech, M., Fuller, S., Flügel, R., & Löchelt, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7995-8007.2001 · Cited by 72
“amino-terminal acyl moiety and other motifs in MA (16, 57).”
BackgroundThe molecular basis of HIV capsid assembly—five years of progress
Adamson, C. S., & Jones, I. M. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.418 · Cited by 69
“The subsequent cleavage event releases MA from CA-SP1 [126] leaving a mature MA associated with the membrane albeit with a considerably weaker affinity than MA within the context of Gag [73,77].”
BackgroundLee, Y. M., Liu, B., & Yu, X.-F. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5654-5662.1999 · Cited by 67
“It has also been proposed that HIV-1 Gag protein in the cytosol may adapt a different conformation once it has bound to the membrane (31, 45).”
BackgroundSingle-Cell and Single-Cycle Analysis of HIV-1 Replication
Holmes, M., Zhang, F., & Bieniasz, P. D. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004961 · Cited by 66
Virus assembly and plasma membrane domains: Which came first?
Kerviel, A., Thomas, A., Chaloin, L., Favard, C., & Muriaux, D. M. (2012) · Virus Research · doi:10.1016/j.virusres.2012.08.014 · Cited by 72
Biochemical Characterization of Rous Sarcoma Virus MA Protein Interaction with Membranes
Dalton, A. K., Murray, P. S., Murray, D., & Vogt, V. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6227-6238.2005 · Cited by 65
“model for the sequence of Gag(88-100) based on the C-terminal regions of other”
BackgroundMethodInfluentialMultiple, Switchable Protein:RNA Interactions Regulate Human Immunodeficiency Virus Type 1 Assembly
Bieniasz, P. D., & Telesnitsky, A. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-092917-043448 · Cited by 66
Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation
Barros, M., Heinrich, F., Datta, S. A. K., Rein, A. R., Karageorgos, I. L., Nanda, H., & Lösche, M. (2016) · Journal of Virology · doi:10.1128/jvi.02820-15 · Cited by 69
“In cells, myristoylation of Gag is a prerequisite for plasma membrane targeting (49–52), since mutation of the N-terminal glycine completely blocks membrane localization of Gag and the subsequent assembly of infectious virus particles (53).”
BackgroundCrystal structure of bet3 reveals a novel mechanism for Golgi localization of tethering factor TRAPP
Kim, Y., Sohn, E. J., Seo, J., Lee, K., Lee, H., Hwang, I., Whiteway, M. S., Sacher, M. G., & Oh, B. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb871 · Cited by 62
“Although many examples of lipidation-mediated compartment-specific localization of cytosolic proteins are found in the literatur”
Retroviral Matrix Proteins: A Structural Perspective
Conte, M. R., & Matthews, S. (1998) · Virology · doi:10.1006/viro.1998.9206 · Cited by 61
“According to the hypothesis of a conformational myristoyl switch mechanism (Zhou and Resh, 1996; Spearman et al., 1997), the myristic acid has been proposed to be a key regulator of the Gag–membrane and MA–membrane interaction.”
BackgroundSimon, J. H., Carpenter, E. A., Fouchier, R. A. M., & Malim, M. H. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2667-2674.1999 · Cited by 62
“It was therefore unexpected when processed p17 (MA) was found to be present in postentry HIV-1 nucleoprotein complexes (7, 20, 25, 39); a conformational switch that results in the myristoyl residue becoming hidden from the surface of MA (53, 60), in conjunction with the phosphorylation of MA (6, 24, 25, 33), is though…”
BackgroundAfrican Swine Fever Virus Proteinase Is Essential for Core Maturation and Infectivity
Alejo, A., Andrés, G., & Salas, M. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5571-5577.2003 · Cited by 60
“This anomaly in the defective particles might hinder the disassembly process, as has been postulated for the uncoating of the incoming particle during human immunodeficiency virus infection (32, 49).”
BackgroundConte, M. R., Rumlová, M., Hunter, E., Ruml, T., & Matthews, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5819 · Cited by 59
“Zhou and Resh (1996) have proposed that, when the myristate is exposed, it enables HIV Gag to bind todirects Gag to an intracellular assembly site.”
BackgroundMethodInfluentialLlewellyn, G. N., Grover, J. R., Olety, B., & Ono, A. (2013) · Journal of Virology · doi:10.1128/jvi.00040-13 · Cited by 58
Retroviral matrix and lipids, the intimate interaction
Hamard-Péron, É., & Muriaux, D. M. (2011) · Retrovirology · doi:10.1186/1742-4690-8-15 · Cited by 64
“This supports a pre-existing hypothesis first proposed by Zhou et al [31]: the existence of a “myristyl switch”, that is actually an entropic equilibrium between the [T] conformation that sequesters the myristate inside the protein, and the [R] conformation that promotes trimeristation and exposure of the myristate mo…”
BackgroundInfluentialGhanam, R. H., Samal, A. B., Fernandez, T. F., & Saad, J. S. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00055 · Cited by 66
“In vitro studies have established that Gag binds membranes more efficiently than the isolated MA protein (Zhou and Resh, 1996; Spearman et al., 1997; Hermida-Matsumoto and Resh, 1999; Ono and Freed, 1999; Paillart and Gottlinger, 1999; Bouamr et al., 2003).”
BackgroundInlora, J., Collins, D. R., Trubin, M. E., Chung, J. Y. J., & Ono, A. (2014) · mBio · doi:10.1128/mbio.02202-14 · Cited by 61
Human Immunodeficiency Virus Type 1 Matrix Protein Assembles on Membranes as a Hexamer
Alfadhli, A., Huseby, D. L., Kapit, E., Colman, D., & Barklis, E. (2006) · Journal of Virology · doi:10.1128/jvi.02122-06 · Cited by 53
“Evidence supports a myristoyl switch model for HIV, in which the MA myristate is partially buried until PrGag oligomerization, when its hydrocarbon tail is exposed, fostering membrane binding and virus assembly (5, 15, 22, 47, 49, 54, 56, 61).”
BackgroundElectrostatic Interactions and Binding Orientation of HIV-1 Matrix Studied by Neutron Reflectivity
Nanda, H., Datta, S. A. K., Heinrich, F., Lösche, M., Rein, A. R., Krueger, S., & Curtis, J. E. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.07.062 · Cited by 53
Wu, Z., Alexandratos, J. N., Ericksen, B., Lubkowski, J. T., Gallo, R. C., & Lu, W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404649101 · Cited by 53
Guo, X., Roldán, A., Hu, J., Wainberg, M. A., & Liang, C. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1803-1812.2005 · Cited by 53
“Indeed, a correlation between Gag multimerization and Gag-membrane binding has been proposed in a “myristyl switch” model (21, 42, 45, 57).”
BackgroundThe frantic play of the concealed HIV envelope cytoplasmic tail
da Silva, E. S., Mulinge, M. M., & Perez-Bercoff, D. (2013) · Retrovirology · doi:10.1186/1742-4690-10-54 · Cited by 51
“The myristoylated moiety is cotranslationally coupled to the p55 MA domain, and its exposure is regulated by binding to calmodulin: binding to calmodulin induces conformational changes within MA [93,94] which lead to p55 binding to lipid rafts [95-97], where it oligomerises [73,86,87,98], through the C-terminal domain…”
BackgroundMembrane Targeting Properties of a Herpesvirus Tegument Protein-Retrovirus Gag Chimera
Bowzard, J. B., Visalli, R. J., Wilson, C., Loomis, J. S., Callahan, E. M., Courtney, R. J., & Wills, J. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8692-8699.2000 · Cited by 51
“Why is the M domain inactive in this context? It is possible that cleavage of MA from the remainder of Gag allows conformational rearrangements that disrupt the M domain and prevent plasma membrane binding (37, 50).”
BackgroundChen, S. S.-L., Lee, S.-F., & Wang, C.-T. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9925-9938.2001 · Cited by 49
“HIVgptmyr encodes a glycine-to-alanine substitution at residue 2 of MA, which abolishes the Pr55 myristylation signal and severely impairs Gag membrane binding (7, 47, 55, 72).”
BackgroundMembrane-induced alterations in HIV-1 gag and matrix protein-protein interactions
Scarlata, S., Ehrlich, L. S., & Carter, C. A. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1615 · Cited by 48
Fogarty, K., Chen, Y., Grigsby, I. F., Macdonald, P. J., Smith, E. M., Johnson, J. L., Rawson, J. M. O., Mansky, L. M., & Mueller, J. D. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.02.008 · Cited by 44
“This result is consistent with the myristoyl switch model (16,17,23,24).”
ResultRoles played by acidic lipids in HIV-1 Gag membrane binding
Olety, B., & Ono, A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.06.015 · Cited by 50
Jäger, S., Gottwein, E., & Kräusslich, H. (2007) · Journal of Virology · doi:10.1128/jvi.00044-07 · Cited by 47
“This difference in membrane binding is believed to be due to a myristoyl switch masking the hydrophobic properties of MA (41, 49).”
BackgroundSolution structure and dynamics of the bioactive retroviral M domain from rous sarcoma virus
McDonnell, J. M., Fushman, D., Cahill, S. M., Zhou, W., Wolven, A., Wilson, C., Nelle, T. D., Resh, M. D., Wills, J. W., & Cowburn, D. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1788 · Cited by 47
Self-citationMass spectrometric characterization of lipid‐modified peptides for the analysis of acylated proteins
Hoffman, M. D., & Kast, J. (2006) · Journal of Mass Spectrometry · doi:10.1002/jms.981 · Cited by 46
Metadata
- Authors
- Zhou, W., & Resh, M. D.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- ORCID
- Resh, M D
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1996-12
- Volume
- 70
- Issue
- 12
- Pages
- 8540-8548
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC190946
- OpenAlex
- W2102965972
- Cited by
- 226
- References
- 47
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 10 · 2013: 10 · 2012: 13
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 72309, R01CA072309)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- HIV-1, Pr55gag, membrane binding, myristate, myristoylation, plasma membrane targeting, viral assembly, nuclear targeting, protein conformational change, liposome binding, subcellular localization
- MeSH terms
- Animals, Epitopes, Cell Membrane, Humans, Myristic Acids, Protein Precursors, Viral Proteins, Signal Transduction, HIV Antigens, HIV-1, Gene Products, gag, Sequence Deletion, COS Cells, Myristic Acid, gag Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review